Get the Stockscreener App
26.12
192.33%
16.99
Sensei Biotherapeutics Inc stock is traded at $26.12, with a volume of 9.74M.
It is up +192.33% in the last 24 hours and up +155.65% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$9.13
Open:
$28
24h Volume:
9.74M
Relative Volume:
46.92
Market Cap:
$32.81M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-21.95
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
+201.92%
1M Performance:
+155.65%
6M Performance:
+222.73%
1Y Performance:
+183.82%
1-Day Range:
$22.07
$31.94
1-Week Range:
$8.79
$31.94
52-Week Range:
$5.00
$31.94
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
26.01 | 11.52M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.24 | 121.26B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
791.06 | 83.89B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
842.10 | 52.20B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.81 | 44.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
356.25 | 39.27B | 4.98B | 69.60M | 525.67M | 0.5198 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
Sensei Biotherapeutics (SNSE) Shares Soar After $200M Acquisitio - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance - HIT Consultant
Sensei Jumps 150% On Faeth Therapeutics Buyout And $200M Financing - Nasdaq
Sensei Biotherapeutics Closes Faeth Acquisition and Financing - TipRanks
Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition - Investing.com
SNSE: Acquisition and $200M financing position the combined entity as a leader in multi-node cancer therapies - TradingView
Sensei Biotherapeutics (SNSE) Acquires Faeth Therapeutics to Expand Pipeline - GuruFocus
SNSE: Acquisition and $200M financing advance a novel cancer therapy toward key clinical milestones - TradingView
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire
What is the Moat Score of Sensei Biotherapeutics Inc.Earnings Risk Summary & Weekly High Return Stock Forecasts - mfd.ru
Sensei Biotherapeutics Expands Board, Adds Finance Expertise - TipRanks
Is Sensei Biotherapeutics Inc. stock a top performer YTDJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - mfd.ru
Is Sensei Biotherapeutics Inc.’s growth already priced inPortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
Can Sensei Biotherapeutics Inc. be the next market leaderJuly 2025 Sector Moves & Weekly Setup with ROI Potential - mfd.ru
What is Sensei Biotherapeutics Incs TAM Total Addressable MarketDay Trade & Scalable Portfolio Growth Methods - baoquankhu1.vn
Market Rankings: Is Sensei Biotherapeutics Inc. a speculative investmentTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
AI Stocks: What is Sensei Biotherapeutics Incs revenue forecastProfit Target & Safe Capital Allocation Plans - baoquankhu1.vn
Portfolio Recap: Does Sensei Biotherapeutics Inc have pricing powerDay Trade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Valuation Update: Will FG Merger II Corp Equity Right outperform its industry peersNew Guidance & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Treasury Yields: Will Sensei Biotherapeutics Inc benefit from rising consumer demandMarket Volume Summary & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Can Sensei Biotherapeutics Inc. stock rebound after recent weaknessEarnings Miss & Weekly High Potential Stock Alerts - bollywoodhelpline.com
Investor Mood: Whats the MACD signal for Sensei Biotherapeutics Inc2025 Support & Resistance & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Death Cross: What is the Moat Score of Sensei Biotherapeutics IncM&A Rumor & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Retail Surge: Does EQVWS outperform in volatile markets2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Panic Selling: Is Sensei Biotherapeutics Inc in a bullish channelJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Aug Big Picture: Can Sensei Biotherapeutics Inc be the next market leaderJuly 2025 Trends & Free Community Consensus Stock Picks - baoquankhu1.vn
Published on: 2026-01-11 01:29:32 - Улправда
Earnings Update: Will Sensei Biotherapeutics Inc 4070 stock sustain dividend payouts2025 Institutional Moves & Low Risk Entry Point Tips - Bộ Nội Vụ
Why retail investors favor Sensei Biotherapeutics Inc. stockEarnings Trend Report & Accurate Technical Buy Alerts - Улправда
Sensei Biotherapeutics, Inc.Common Stock (NQ: SNSE - FinancialContent
Why Sensei Biotherapeutics Inc. stock is trending among retail tradersPortfolio Return Summary & Weekly Top Stock Performers List - Улправда
Los Angeles Daily NewsSensei Biotherapeutics, Inc.Common Stock (Nasdaq:SNSE) Stock Quote - FinancialContent
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Aug Setups: Why retail investors favor Sensei Biotherapeutics Inc stock2025 Market Outlook & Verified High Yield Trade Plans - moha.gov.vn
What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN
Will Sensei Biotherapeutics Inc. stock deliver shareholder valueChart Pattern Recognition & Grow Steadily With Our Wealth Roadmap - bollywoodhelpline.com
Sensei Biotherapeutics (NASDAQ:SNSE) Upgraded to “Hold” at Wall Street Zen - Defense World
Sensei Biotherapeutics Updates Executive Retention and Compensation Agreements - TipRanks
Dividend Watch: Will Sensei Biotherapeutics Inc. stock deliver shareholder valueWeekly Gains Summary & Verified Momentum Watchlists - Улправда
How Sensei Biotherapeutics Inc. stock performs in rising dollar environmentEntry Point & Community Verified Swing Trade Signals - Улправда
Sensei Biotherapeutics Earnings Notes - Trefis
What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump? - Sahm
Major Stakeholders Offload Shares in Sensei Biotherapeutics! - TipRanks
Shareholder Peyer Files To Sell 841 Of Sensei Biotherapeutics Inc [SNSE] - TradingView — Track All Markets
Major Stakeholders Offload Sensei Biotherapeutics Shares! - TipRanks
Cambrian Biopharma Sells Shares of Sensei Biotherapeutics - TradingView — Track All Markets
Dir Peyer Sells 21,295 ($232.7K) Of Sensei Biotherapeutics Inc [SNSE] - TradingView — Track All Markets
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Down 8% – What’s Next? - Defense World
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensei Biotherapeutics Inc Stock (SNSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc | 10% Owner |
Dec 09 '25 |
Option Exercise |
6.40 |
395 |
2,528 |
155,983 |
| Cambrian BioPharma Inc | 10% Owner |
Dec 09 '25 |
Sale |
8.25 |
6,612 |
54,575 |
155,142 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Option Exercise |
6.40 |
395 |
2,528 |
155,983 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Sale |
7.96 |
3,507 |
27,903 |
155,142 |
| Peyer James | 10% Owner |
Dec 08 '25 |
Sale |
8.59 |
3,105 |
26,672 |
158,254 |
0.23%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):